Lippi G, Mattiuzzi C (2020) The global burden of pancreatic cancer. Arch Med Sci 16:820–824. https://doi.org/10.5114/aoms.2020.94845

Article  PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5–29

PubMed  Google Scholar 

Grossberg AJ, Chu LC, Deig CR et al (2020) Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin 70(5):375–403

PubMed  PubMed Central  Google Scholar 

NCCN guidelines—pancreatic adenocarcinoma (Version: 1.2024) https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1455

Szturz P, Vermorken JB (2021) Oligometastatic cancer: key concepts and research opportunities for 2021 and beyond. Cancers 13:2518

Article  PubMed  PubMed Central  Google Scholar 

Takda T, Sasaki T, Ichinose J et al (2023) Outcomes of lung oligometastasis in pancreatic cancer. Jpn J Clin Oncol 53(12):1144–1152. https://doi.org/10.1093/jjco/hyad111

Article  Google Scholar 

Specchia ML, Friscale EM, Carini E et al (2020) The impact of tumor board on cancer care: evidence from an umbrella review. BMC Health Serv Res 20:73

Article  PubMed  PubMed Central  Google Scholar 

Prades J, Remue E, van Hoof E et al (2015) Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes. Health Policy 119(4):464–467

Article  PubMed  Google Scholar 

Arnaoutakis GJ, Rangachari D, Laheru DA et al (2011) Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival. J Gastrointest Surg 15:1611–1617

Article  PubMed  PubMed Central  Google Scholar 

Miyashita Y, Ose N, Okami J et al (2023) Outcomes of surgical resection for pulmonary metastasis from pancreatic cancer. Surg Today 53:1236–1246. https://doi.org/10.1007/s00595-023-02701-0

Article  PubMed  PubMed Central  Google Scholar 

Miyasaka M, Noji T, Ohtaka K et al (2018) Long‑term survival after repeated resection of metachronous lung metastases from pStage IA pancreatic adenocarcinoma. Clin J Gastroenterol 11:53–61. https://doi.org/10.1007/s12328-017-0781-9

Article  PubMed  Google Scholar 

Gao J, Wang J, Guan C et al (2024) Advances in drug therapy for metastatic pancreatic ductal adenocarcinoma. J Cancer 15(8):2214–2228. https://doi.org/10.7150/jca.89788

Article  CAS  PubMed  PubMed Central  Google Scholar 

AIOM guidelines—Exocrine pancreatic cancer. (Ed. 2021) https://www.aiom.it/linee-guida-aiom-2024-carcinoma-del-pancreas-esocrino/

Pausch TM, Liu X, Cui J et al (2021) Survival benefit of resection surgery for pancreatic ductal adenocarcinoma with liver metastases: a propensity score-matched SEER database analysis. Cancers 14(1):57. https://doi.org/10.3390/cancers14010057

Article  PubMed  PubMed Central  Google Scholar 

Guckenberger M, Lievens Y, Bouma AB et al (2020) Characterisation and classification of oligometastatic disease: a European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus recommendation. Lancet Oncol 21(1):e18-28. https://doi.org/10.1016/S1470-2045(19)30718-1

Article  PubMed  Google Scholar 

Damanakis AI, Ostertag L, Waldschmidt D et al (2019) Proposal for a definition of “oligometastatic disease in pancreatic cancer.” BMC Cancer 19(1):1261. https://doi.org/10.1186/s12885-019-6448-9

Article  PubMed  PubMed Central  Google Scholar 

Kanzaki R, Inoue M, Kimura T et al (2017) Role of pulmonary metastasectomy in colorectal cancer in the era of modern multidisciplinary therapy. Surg Today 47(9):1111–1118

Article  PubMed  Google Scholar 

Zizzo M, Galeone C, Braglia L et al (2020) Long-term outcomes after surgical resection for synchronous or metachronous hepatic and pulmonary colorectal cancer metastases. Digestion 101(2):144–155. https://doi.org/10.1159/000497223

Article  PubMed  Google Scholar 

Kanzaki R, Susaki Y, Takami K et al (2020) Long-term outcomes of pulmonary metastasectomy for uterine malignancies: a multi-institutional study in the current era. Ann Surg Oncol 27(10):3821–3828. https://doi.org/10.1245/s10434-020-08426-5

Article  PubMed  PubMed Central  Google Scholar 

Decoster C, Gilabert M, Autret A et al (2016) Heterogeneity of metastatic pancreatic adenocarcinoma: lung metastasis show better prognosis than liver metastasis-a case control study. Oncotarget 7:45649–45655

Article  PubMed  PubMed Central  Google Scholar 

Morimoto D, Yamada S, Sonohara F et al (2020) Characteristics of lung metastasis as an initial recurrence pattern after curative resection of pancreatic cancer. Pancreas 49:699–705

Article  PubMed  Google Scholar 

Liu KH, Hung CY, Hsueh SW et al (2019) Lung metastases in patients with Stage IV pancreatic cancer: prevalence, risk factors, and survival impact. J Clin Med 8(9):1402. https://doi.org/10.3390/jcm8091402. (PMID: 31500146; PMCID: PMC6780197)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Homma Y, Endo I, Matsuyama R et al (2022) Outcomes of lung metastasis from pancreatic cancer: a nationwide multicenter analysis. J Hepatobiliary Pancreat Sci 29(5):552–561

Article  PubMed  Google Scholar